Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Plos One|June 22, 2012
Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 functionJane Muret, Meriem Hasmim, Izabela Stasik, et al.
Cancer Research|July 20, 2007
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challengeAntonio Scardino, Maurizio Alimandi, Pierpaolo Correale, et al.
Cancer Immunology Research|September 7, 2019
AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated CytotoxicityStéphane Terry, Abderemane Abdou, Agnete S T Engelsen, et al.
Blood|June 25, 2005
Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitorsJulien Giron-Michel, Massimo Giuliani, Manuela Fogli, et al.
The Journal of Clinical Investigation|February 3, 2004
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapyDavid-Alexandre Gross, Stéphanie Graff-Dubois, Paule Opolon, et al.
Oncoimmunology|January 4, 2018
BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)Audrey Benyamine, Céline Loncle, Etienne Foucher, et al.
International Journal of Cancer|January 9, 2004
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopesOlivier Faure, Stéphanie Graff-Dubois, Laurent Bretaudeau, et al.
Plos One|May 22, 2008
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15Massimo Giuliani, Julien Giron-Michel, Simone Negrini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysisMuhammad Zaeem Noman, Stéphanie Buart, Jos Van Pelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2025
High circulating IL-6/IL-8 is associated with intratumoral myeloid contexture and poor outcomes in advanced renal cell carcinoma patients treated with PD-1 blockadeLucia Carril-Ajuria, Ronan Flippot, Marie Naigeon, et al.
Pageof 21